Show simple item record

Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers

dc.contributor.authorDomino, Edward F.en_US
dc.contributor.authorMinoshima, Satoshien_US
dc.contributor.authorGuthrie, Sally K.en_US
dc.contributor.authorOhl, Lindaen_US
dc.contributor.authorNi, Lisongen_US
dc.contributor.authorKoeppe, Robert A.en_US
dc.contributor.authorZubieta, Jon-Karen_US
dc.date.accessioned2006-04-19T14:02:45Z
dc.date.available2006-04-19T14:02:45Z
dc.date.issued2000-12-01en_US
dc.identifier.citationDomino, Edward F.; Minoshima, Satoshi; Guthrie, Sally; Ohl, Linda; Ni, Lisong; Koeppe, Robert A.; Zubieta, Jon-Kar (2000)."Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers." Synapse 38(3): 313-321. <http://hdl.handle.net/2027.42/34989>en_US
dc.identifier.issn0887-4476en_US
dc.identifier.issn1098-2396en_US
dc.identifier.urihttps://hdl.handle.net/2027.42/34989
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=11020234&dopt=citationen_US
dc.description.abstractThe hypothesis for this research was that regional cerebral blood flow (rCBF) would increase following nasal nicotine administration to overnight abstinent tobacco smokers in relationship to the known brain distribution of nicotinic cholinergic receptors (nAChRs). Nine male and nine female healthy adult smokers were studied. They abstained overnight from tobacco products for 10 or more hours prior to study the next morning. Nicotine nasal spray was given in doses of 1–2.5 mg total with half in each nostril while the subject was awake and resting in a supine position. Oleoresin of pepper solution in a similar volume was used as an active placebo to control for the irritating effects of nicotine. Both substances were given single blind to the subjects. Positron emission tomography (PET) with H 2 15 O was used to measure rCBF. The data from each subject volunteer were normalized to global activity to better assess regional brain changes. Both nasal nicotine and pepper spray produced similar increases in CBF in somesthetic area II, consistent with the irritant effects of both substances. The mean rCBF effects of nasal pepper were subtracted from those of nasal nicotine to determine the actions of nicotine alone. The latter produced increases in rCBF in the thalamus, pons, Brodman area 17 of the visual cortex, and cerebellum. Some brain areas that contain a large number of nAChRs, such as the thalamus, showed an increase in CBF. Other areas that have few nAChRs, such as the cerebellum, also showed an increase in relative CBF. The hippocampal/parahippocampal areas showed greater regional decreases (left) and lesser increases (right) in CBF that correlated with the increase in plasma arterial nicotine concentrations. The results obtained indicate complex primary and secondary effects of nicotine in which only some regional brain CBF changes correlate with the known distribution of nAChR. No gender differences were noted. Synapse 38:313–321, 2000. © 2000 Wiley-Liss, Inc.en_US
dc.format.extent394801 bytes
dc.format.extent3118 bytes
dc.format.mimetypeapplication/pdf
dc.format.mimetypetext/plain
dc.language.isoen_US
dc.publisherJohn Wiley & Sons, Inc.en_US
dc.subject.otherLife and Medical Sciencesen_US
dc.subject.otherNeuroscience, Neurology and Psychiatryen_US
dc.titleNicotine effects on regional cerebral blood flow in awake, resting tobacco smokersen_US
dc.typeArticleen_US
dc.rights.robotsIndexNoFollowen_US
dc.subject.hlbsecondlevelMolecular, Cellular and Developmental Biologyen_US
dc.subject.hlbsecondlevelNeurosciencesen_US
dc.subject.hlbsecondlevelPublic Healthen_US
dc.subject.hlbtoplevelHealth Sciencesen_US
dc.subject.hlbtoplevelScienceen_US
dc.description.peerreviewedPeer Revieweden_US
dc.contributor.affiliationumDepartment of Pharmacology, University of Michigan, Ann Arbor, Michigan ; Department of Pharmacology, University of Michigan, Ann Arbor, MI 48109-0632en_US
dc.contributor.affiliationumDepartment of Internal Medicine (Nuclear Medicine), University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationumCollege of Pharmacy, University of Michigan, Ann Arbor, Michigan ; Department of Psychiatry, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationumMental Health Research Institute, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Pharmacology, University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationumDepartment of Internal Medicine (Nuclear Medicine), University of Michigan, Ann Arbor, Michiganen_US
dc.contributor.affiliationumMental Health Research Institute, University of Michigan, Ann Arbor, Michigan ; Department of Psychiatry, University of Michigan, Ann Arbor, Michiganen_US
dc.identifier.pmid11020234en_US
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/34989/1/10_ftp.pdfen_US
dc.identifier.doihttp://dx.doi.org/10.1002/1098-2396(20001201)38:3<313::AID-SYN10>3.0.CO;2-6en_US
dc.identifier.sourceSynapseen_US
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.